Ocumension Therapeutics announce that Mr. Zhenyu ZHANG has been appointed as an independent non-executive director, the chairman of the remuneration committee and a member of the nomination committee and audit committee of the Company with effect from April 8, 2022. Mr. Zhang, aged 46, has more than 20 years of experience in legal and corporate compliance practice. He currently serves as the vice president responsible for legal, compliance and governmental affairs of Greater China region for The a2 Milk Company Limited.